by GlobeNewsWire | Apr 13, 2016 | Globe Newswire
– Mayo Clinic, University of Minnesota, and ChromaDex to Collaborate on Study – IRVINE, Calif., April 13, 2016 (GLOBE NEWSWIRE) — Thorne Research and ChromaDex Corp. (OTCQX:CDXC) announced today a research endeavor with Mayo Clinic and the University...
by GlobeNewsWire | Apr 12, 2016 | Globe Newswire
IRVINE, Calif., April 12, 2016 (GLOBE NEWSWIRE) — ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients, that creates science-based solutions for dietary supplement, food and beverage, skin care, sports...
by GlobeNewsWire | Mar 17, 2016 | Globe Newswire
– Company Expects to Report Record Revenue for Q1 2016 — Led by NIAGEN®, Company Expects Strong Revenue Growth in 2016 -IRVINE, Calif., March 17, 2016 (GLOBE NEWSWIRE) — ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and...
by GlobeNewsWire | Mar 10, 2016 | Globe Newswire
– Broader Study Will Build Upon the Successful Results of the First Trial Which Demonstrated NIAGEN® is a Safe, Effective NAD+ Precursor in Humans – IRVINE, Calif., March 10, 2016 (GLOBE NEWSWIRE) — ChromaDex Corp. (OTCQX:CDXC), an innovator of...
by GlobeNewsWire | Feb 22, 2016 | Globe Newswire
IRVINE, Calif., Feb. 22, 2016 (GLOBE NEWSWIRE) — ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition,...